Clinical Trials
524 articles
Participating in clinical trials can give you access to the latest treatments for pancreatic cancer.
I Have So Much to Live For
Mary Gillam knew that she had to fight after her pancreatic cancer diagnosis. She traveled to where she would get the best treatment and a clinical trial.
Take the Time to Consider Your Options
Rachel Santmyer-Flores decided to look at her options before choosing a clinical trial of PEGPH20 for her pancreatic cancer treatment.
Facing My Biggest Danger: Pancreatic Cancer
After Gary Carmichael finally found the source of his digestive troubles, he had a Whipple procedure to remove his pancreatic cancer.
Report Highlights Potential of TCR Therapy
Read about the potential of TCR therapy, a technique used with success for one pancreatic cancer patient in a groundbreaking immunotherapy clinical trial.
Pancreatic Cancer Research Highlights from ASCO Annual Meeting
The 2025 ASCO meeting featured pancreatic cancer research including a new treatment modality and a new treatment combination.
Taking a Different Approach to Pancreatic Cancer Treatment
When Dr. Stephen Bigelsen was diagnosed with stage IV pancreatic cancer, he found a doctor to created a personalized treatment plan.
2022 AACR Annual Meeting Update
The 2022 AACR Annual Meeting featured the latest in pancreatic cancer breakthroughs, research in artificial intelligence, screening, detection, and vaccines.
Radiotherapy Implant plus Standard Chemotherapy
The OncoSil radiotherapy implant device is being tested on pancreatic cancer in a clinical trial that combines it with standard chemotherapy.
Precision Promise Places Patients at Center of Research
Dr. Diane Simeone explains the different approach to pancreatic cancer clinical trials taken by the Precision Promise program.
AVENGER 500 Clinical Trial Shows No Overall Survival Benefit
Data from the AVENGER 500 clinical trial explains why the trial’s goal was not met. A new trial with a different approach has launched.
Two-Drug Combo Targets KRAS and Fights Resistance
Researcher Hervé Tiriac leads a clinical trial for a new drug combination targeting KRAS and chemotherapy resistance.
An Expanded Access Trial for Cancer Patients with Specific Mutations
An investigational drug is being used in an expanded access trial for advanced pancreatic and other cancer patients with specific genetic changes.
A New Treatment for Progressive Metastatic Pancreatic Cancer
Researchers are testing a new drug for second-line therapy (after initial treatment stops working) in metastatic pancreatic cancer.
Exploring the Better Treatment for Stable Metastatic Pancreatic Cancer
For patients with stable metastatic pancreatic cancer, a clinical trial compares standard chemotherapy with immunotherapy.
Discovering the Better Drug Treatment After Surgery for Pancreatic Cancer
A clinical trial compares two chemotherapy regimens to see which one is more effective at knocking out remaining cancer cells.